pharmaceuticals
Sun will be responsible for development, regulatory filings and manufacturing of the drugs, while AstraZeneca will exclusively promote and distribute the products in China, according to a filing here to Indian stock exchanges.
AstraZeneca to distribute Sun Pharma cancer medicines in China
06 Nov 2019 12:47 PM

Shares of Sun Pharma rose as much as 5.4 per cent to a nine-week high after the announcement.

  • « First
  • « Previous
  • 1
  • Next »
  • Last »

1 of 1